Solomont Bailis Ventures

Solomont Bailis Ventures. It is a venture capital firm based in Boston, Massachusetts, specializing in early-stage investments within the healthcare and technology sectors. Founded in 2010 by former United States Ambassador to Spain Alan D. Solomont and seasoned investor Chelsea A. Bailis, the firm leverages deep expertise in public policy, healthcare innovation, and entrepreneurship to support transformative companies. Its investment thesis centers on backing entrepreneurs whose solutions address significant challenges in aging populations, chronic disease management, and healthcare accessibility.

History

The firm was established in 2010 following the convergence of its founders' distinct career paths. Alan D. Solomont, after serving as the United States Ambassador to Spain and Andorra under the Obama administration, combined his extensive experience in public service and healthcare policy with the investment acumen of Chelsea A. Bailis, who had a background in private equity and healthcare services. The founding coincided with a period of significant legislative change, including the passage of the Affordable Care Act, which created new opportunities in health technology. Early investments were concentrated in the New England ecosystem, with a focus on startups emerging from institutions like the Massachusetts Institute of Technology and Harvard University. Over the subsequent decade, the firm expanded its geographic reach and sector focus, participating in significant funding rounds alongside major firms like General Catalyst and Bessemer Venture Partners.

Investment focus

The firm primarily targets Seed and Series A funding rounds, providing capital to startups at the intersection of healthcare, technology, and social impact. A core thematic pillar is supporting innovations for the aging in place movement, including technologies in remote patient monitoring, digital therapeutics, and predictive analytics. Another major focus area is value-based care enablement, investing in platforms that streamline operations for Accountable Care Organizations and improve outcomes in Medicare Advantage plans. The firm also actively seeks out companies developing solutions for behavioral health, women's health, and health equity, often engaging with policymakers at organizations like the Centers for Medicare & Medicaid Services to understand regulatory tailwinds. Investments are characterized by a hands-on partnership model, where the team assists with business development, regulatory strategy, and corporate governance.

Portfolio companies

The firm's portfolio comprises a diverse array of companies driving innovation across its core sectors. Notable investments in digital health include Biofourmis, a leader in physiology analytics, and Wellframe, a care management platform acquired by HealthEdge Software. In the aging and home-based care space, the firm backed Honor Technology, a network for home care services, and CareAcademy, which provides training for caregivers. Other significant portfolio companies involve Cyft, which utilizes artificial intelligence for risk stratification, and Lydia AI, focused on health risk assessment. The firm has also invested in companies tackling specific disease states, such as Urovant Sciences in urology and Elektra Health in menopause care. Successful exits have occurred through acquisitions by larger entities like Teladoc Health and UnitedHealth Group.

Leadership and team

The firm is led by its founding partners, Alan D. Solomont and Chelsea A. Bailis. Alan D. Solomont, who also serves as Dean of the Jonathan M. Tisch College of Civic Life at Tufts University, brings unparalleled connections in government relations and a deep understanding of healthcare policy from his tenure on the board of the Corporation for National and Community Service. Chelsea A. Bailis directs the investment strategy, drawing on prior experience at Bain Capital and an operational role at Partners HealthCare. The senior team includes principals and associates with backgrounds from leading institutions such as the Cleveland Clinic, McKinsey & Company, and Goldman Sachs. This multidisciplinary team collaborates closely with an extensive network of venture partners, industry advisors, and Kauffman Fellows to source deals and support portfolio company growth.

Impact and recognition

The firm is recognized for its dual emphasis on financial returns and measurable social impact, often aligning its investments with the United Nations Sustainable Development Goals. It has been an active participant in initiatives like the White House Conference on Aging and advocacy efforts with AARP to promote technology-enabled aging. The firm's work has been featured in publications such as Forbes, STAT News, and Modern Healthcare. Its founders are frequent speakers at industry conferences including HLTH and J.P. Morgan Healthcare Conference. While not primarily an impact investing fund, its focus on improving health outcomes and reducing costs in systems like the Veterans Health Administration has garnered recognition from organizations focused on social entrepreneurship.

Category:Venture capital firms of the United States Category:Companies based in Boston Category:Financial services companies established in 2010